Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
1.030
-0.080 (-7.21%)
At close: Nov 7, 2024, 4:00 PM
1.080
+0.050 (4.85%)
After-hours: Nov 7, 2024, 6:07 PM EST
Carisma Therapeutics Employees
Carisma Therapeutics had 107 employees as of December 31, 2023.
Employees
107
Change
n/a
Growth
n/a
Revenue / Employee
$193,551
Profits / Employee
-$677,579
Market Cap
42.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 107 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| SHL Telemedicine | 583 |
| HOOKIPA Pharma | 179 |
| Accelerate Diagnostics | 134 |
| Vicarious Surgical | 131 |
| CollPlant Biotechnologies | 75 |
| Immix Biopharma | 17 |
| CalciMedica | 12 |
| VYNE Therapeutics | 10 |
CARM News
- 11 hours ago - Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 2 days ago - Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 - PRNewsWire
- 8 days ago - Carisma Therapeutics Announces Changes to its Board of Directors - PRNewsWire
- 4 weeks ago - Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 - PRNewsWire
- 2 months ago - Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases - PRNewsWire
- 2 months ago - Carisma Therapeutics to Present at Upcoming Conferences - PRNewsWire
- 3 months ago - Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 3 months ago - Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 - PRNewsWire